GL1X · GenesisL1 explorer

MolNFT v1 · #48634 · protein

Minimal human cftr first nucleotide binding domain as a head-to-tail dimer

2PZE · Cystic fibrosis transmembrane conductance regulator: “Minimal human cftr first nucleotide binding domain as a head-to-tail dimer”. X-ray diffraction, 2 ligands (ATP, MG), 1 pocket (best druggability 0.81). MolNFT v1 #48634 on…

PDB
2PZE
Type
protein
Length
445 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cystic fibrosis transmembrane conductance regulator
UniProt
P13569
Ligands
ATP, MG
Pockets
1 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACystic fibrosis transmembrane conductance regulatorprotein22634% helix, 26% strandP13569
BCystic fibrosis transmembrane conductance regulatorprotein21933% helix, 27% strandP13569

Ligands and binding sites

  • ATP · Adenosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111880.810.82127MG, ATP

Interfaces

1 interface between chains.

  • A–B · 873 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2PZE · Minimal human CFTR first nucleotide binding domain as a head-to-tail dimer · the same entry in another collection · chain B against B, TM-score 1.00
  • P13569 · AlphaFold monomer V2.0 prediction for cystic fibrosis transmembrane conductance regulator… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.